Ekso Bionics Holdings, Inc.

    Ekso Bionics Holdings, Inc.

    NNASDAQ:EKSO
    - -
    USD
    - -
    - -
    Ekso Bionics Holdings, Inc.
    NASDAQ:EKSO
    (Nasdaq Stock Market)

    Recent

    price

    - -

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2012
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    2025
    TTM
    USD
    - -
    - -
    - -
    82.73
    102.97
    176.53
    46.46
    41.64
    43.54
    18.6
    13.83
    14.94
    19.77
    13.34
    5.28
    4.15
    Revenue per Share
    - -
    - -
    -0.68
    -524.45
    -288.24
    -419.76
    -184.01
    -99.19
    -37.96
    -33.13
    -12.01
    -17.45
    -16.44
    -8.43
    -4.82
    -5.63
    Basic EPS, GAAP
    - -
    - -
    -0.66
    -256.16
    -234.93
    -323.9
    -200.19
    -81.93
    -49.54
    -18.33
    -13.8
    -17.22
    -13.21
    -7.35
    -4.94
    -4.36
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    - -
    - -
    -0.59
    -1,113.53
    -1,086.32
    -1,425.54
    -910.47
    -628.68
    -573.43
    -416.87
    -256.94
    -259.14
    -258.67
    -186.34
    -108.14
    -96.63
    Book Value per Share
    - -
    - -
    0.83
    353.24
    83.64
    65.99
    130.86
    9.33
    20.68
    9.28
    45.79
    22.91
    7.88
    5.73
    2.1
    -0.63
    Tangible Book Value per Share
    - -
    4
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    1
    1
    1
    2
    3
    Basic Weighted Avg Shares
    - -
    - -
    - -
    5
    9
    14
    7
    11
    14
    9
    11
    13
    18
    18
    13
    12
    Sales/Revenue/Turnover
    - -
    - -
    - -
    -315.26
    -248.94
    -195.36
    -425.47
    -238.53
    -119.56
    -144.76
    -122.96
    -120.48
    -82.67
    -58.35
    -104.12
    -134.06
    Operating Margin (%)
    - -
    - -
    - -
    1
    1
    2
    2
    2
    1
    1
    1
    1
    2
    2
    2
    2
    Depreciation Expense
    - -
    - -
    - -
    -34
    -20
    -23
    -29
    -27
    -12
    -16
    -10
    -15
    -15
    -11
    -12
    -16
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    - -
    - -
    - -
    -633.92
    -226.19
    -165.04
    -396.06
    -238.19
    -87.17
    -178.17
    -86.82
    -116.79
    -83.14
    -63.21
    -91.37
    -135.66
    Profit Margin (%)
    - -
    - -
    - -
    23
    17
    14
    26
    5
    11
    13
    41
    22
    12
    11
    5
    5
    Working Capital
    - -
    - -
    - -
    - -
    - -
    7
    5
    3
    1
    3
    2
    5
    6
    4
    1
    1
    LT Debt
    - -
    - -
    - -
    23
    9
    7
    21
    3
    7
    4
    37
    25
    13
    13
    9
    6
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    USD

    •

    in mil. unless spec.
    Sep'25
    Dec'25
    Mar'26
    ST Debt
    4
    4
    4
    LT Borrowings
    1
    1
    1
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    4
    Shares Outstanding
    3
    4
    4
    Market Capitalization
    10
    19
    30

    Working Capital

    USD

    •

    in mil. unless spec.
    Sep'25
    Dec'25
    Mar'26
    Total Current Assets
    15
    14
    14
    Cash, Cash Equivalents & STI
    3
    1
    4
    Accounts Receivable, Net
    6
    7
    5
    Inventories
    5
    5
    5
    Total Current Liabilities
    9
    9
    9
    Payables & Accruals
    4
    3
    4
    ST Debt
    4
    4
    4
    Deferred Revenue
    2
    2
    2

    Growth Rates

    USD

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    85.8%
    125.83%
    -28.96%
    Free Cash Flow
    -0.48%
    9.02%
    21.31%
    Net Income, GAAP
    0.67%
    -1.06%
    3.22%
    Sales/Revenue/Turnover
    10.91%
    10.49%
    -28.6%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    4
    5
    4
    5
    18
    2025
    3
    2
    4
    3
    13
    2026
    2
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    -2.95
    -1.99
    -1.53
    -2.08
    -8.43
    2025
    -1.71
    -1.24
    -0.54
    - -
    -4.82
    2026
    -1.93
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    USD

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    2026
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business

    Company News

    Company News APIChatGPT

    • globenewswire.com

      ChronoScale Reports Fiscal First Quarter 2027 Results

    • defenseworld.net

      ChronoScale Corporation Common Stock (NASDAQ:CHRN) Stock Passes Above 50-Day Moving Average – What’s Next?

    • globenewswire.com

      ChronoScale Appoints Cenly Chen as Chief Executive Officer to Lead Next Phase of AI Compute Growth

    • defenseworld.net

      Insider Buying: Ekso Bionics (NASDAQ:EKSO) Major Shareholder Purchases $191,142.00 in Stock

    • globenewswire.com

      Ekso Bionics Prices $5.852 million Private Placement

    • gurufocus.com

      Why Applied Digital Stock Is Jumping Today

    • globenewswire.com

      Halper Sadeh LLC Encourages EKSO, FOLD, CWAN, JHG Shareholders to Contact the Firm to Discuss Their Rights

    • prnewswire.com

      $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of EKSO Bionics Holdings, Inc. (NASDAQ: EKSO)

    • feeds.benzinga.com

      Consumer Tech News (Dec 31-Jan 2): Wall Street Braces for Sluggish 2026 Start, AI Spending, and Chip Wars Define Market Pulse & More

    • gurufocus.com

      Applied Digital and EKSO Bionics Plan Strategic Business Combination

    • prnewswire.com

      Halper Sadeh LLC Encourages EKSO, FOLD, WBD, CFLT Shareholders to Contact the Firm to Discuss Their Rights

    • seekingalpha.com

      Applied Digital And The EKSO Transaction: Buy This Clear Story

    • businesswire.com

      EKSO Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of EKSO Bionics Holdings, Inc. Is Fair to Shareholders

    • globenewswire.com

      Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale

    • globenewswire.com

      Ekso Bionics Inks Agreement to Become the Exclusive U.S. Distributor of MediTouch's Groundbreaking BalanceTutor™ Rehabilitation System

    • zacks.com

      Ekso Bionics (EKSO) Upgraded to Buy: Here's Why

    • globenewswire.com

      Ekso Bionics Announces $3.7 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules

    • zacks.com

      Ekso Bionics (EKSO) Reports Q3 Loss, Beats Revenue Estimates

    • globenewswire.com

      Ekso Bionics Reports Third Quarter 2025 Financial Results

    • zacks.com

      Ekso Bionics (EKSO) Upgraded to Buy: Here's What You Should Know